ArticleBMC infectious diseases2018

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.

Ewa Janczewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.